Stockscreener 앱 받기
2.21
5.96%
-0.14
시간 외 거래:
2.22
0.01
+0.45%
Pacific Biosciences Of California Inc 주식(PACB)의 최신 뉴스
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know - sharewise.com
Pacific Biosciences Shares Gain Momentum on Strong Preliminary Results and Clinical Adoption - AD HOC NEWS
Pacific Biosciences of California (NASDAQ:PACB) Shares Down 6.6%Time to Sell? - MarketBeat
Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 11% Over Last Week - 富途牛牛
PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research - Yahoo Finance
Pacific Biosciences of California (NASDAQ:PACB) Trading 6.2% HigherStill a Buy? - MarketBeat
Canada Next-Generation Sequencing (NGS) Market Analysis and - GlobeNewswire
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More - Yahoo Finance
Pacific Biosciences stock gets Buy rating reiteration from Canaccord By Investing.com - Investing.com Canada
Pacific Biosciences' Preliminary Q4 Revenue Climb 14% On DNA Sequencing System Sales - Nasdaq
PACB: Clinical adoption and SPRQ innovation drive growth, with Europe leading and costs dropping - TradingView — Track All Markets
PACB: Clinical growth, Spark Chemistry, and record consumables drive robust momentum into 2026 - TradingView — Track All Markets
PacBio plans collaboration on rare disease therapies with n-Lorem By Investing.com - Investing.com Canada
PacBio (PACB) Advances Childhood Death Research with HiFi Genome Sequencing - GuruFocus
PACB Forecasts Strong FY25 Revenue as Sales Gain Traction - GuruFocus
PacBio Announces Proposed Collaboration with n-Lorem Foundation and EspeRare to Advance Antisense Oligonucleotide Therapies for Rare Genetic Diseases - Quiver Quantitative
PacBio to Support Research on Sudden Unexplained Death in Childhood Using HiFi Whole-Genome Sequencing - Quiver Quantitative
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases - marketscreener.com
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) - marketscreener.com
PacBio HiFi Announces it has Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood - marketscreener.com
Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN
How PacBio (PACB) Is Seeing Its Fair Value Story Shift After ARK’s Share Purchase - Yahoo Finance
PacBio stock dips post latest launch to expand multiomics capabilities - MSN
HOKA Shopping Guide: Can Pacific Biosciences of California Inc. stock double in next 5 years - ulpravda.ru
PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities - sharewise.com
Can PacBio’s New CiFi Method Reshape PACB’s Innovation Story and Recurring Revenue Potential? - Yahoo Finance
Can Pacific Biosciences of California Inc. stock deliver consistent earnings growthOptions Play & Short-Term High Return Strategies - ulpravda.ru
Here's why you should add PacBio stock to your portfolio - MSN
What insider trading reveals about Pacific Biosciences of California Inc. stockTrade Exit Summary & Smart Investment Allocation Tips - Улправда
How Pacific Biosciences of California Inc. (P09) stock trades after rate cutsPortfolio Update Report & Reliable Entry Point Alerts - ulpravda.ru
Is Pacific Biosciences of California Inc. stock a defensive play in 20252025 Earnings Impact & Daily Growth Stock Investment Tips - Улправда
What technical charts say about Pacific Biosciences of California Inc. stockJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - Улправда
Can Pacific Biosciences of California Inc. stock double in next 5 yearsJuly 2025 Highlights & AI Powered Buy and Sell Recommendations - ulpravda.ru
PacBio and UC Davis Researchers Introduce CiFi, A New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from A Single SMRT Cell - marketscreener.com
PacBio introduces CiFi method for chromosome-scale genome assembly By Investing.com - Investing.com Canada
PacBio Introduces CiFi: A Breakthrough Method for Chromosome-Scale Genome Assemblies from Limited Sample Material - Quiver Quantitative
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell - marketscreener.com
New DNA mapping method builds full chromosomes from tiny samples - Stock Titan
Will Pacific Biosciences of California Inc. (P09) stock justify high valuationFed Meeting & Expert Curated Trade Ideas - ulpravda.ru
Barclays analyst is bullish on Pacific Biosciences of California, Inc. (PACB) - MSN
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know - sharewise.com
Here's Why You Should Add PacBio Stock to Your Portfolio - Yahoo Finance
PACB (Pacific Biosciences of California) Land And Improveme - GuruFocus
What analysts say about Pacific Biosciences of California Inc stockOptions Trading Strategies & Low Entry Cost Trading - earlytimes.in
Three Genomics Stocks Worth Tracking This Year - Nasdaq
We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt - simplywall.st
What drives Pacific Biosciences of California Inc P09 stock priceMarket Volatility Update & Missed Nvidia? Don’t Miss This One - earlytimes.in
Retail Surge: Will Pacific Biosciences of California Inc P09 stock rise with strong economyJuly 2025 Volume & Low Risk Entry Point Tips - moha.gov.vn
Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 - The Globe and Mail
PacBio (PACB) Stock Is Up, What You Need To Know - Finviz
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap UpTime to Buy? - MarketBeat
What analysts say about Pacific Biosciences of California Inc P09 stockTechnical Resistance Breaks & Outstanding Capital Returns - earlytimes.in
0.42%
1.96%
자본화:
|
볼륨(24시간):